UK Markets closed

CureVac N.V. (CVAC)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
93.96-4.01 (-4.09%)
At close: 4:00PM EDT

91.90 -2.06 (-2.19%)
After hours: 4:05PM EDT

Currency in USD

Valuation measures

Market cap (intra-day) 517.5B
Enterprise value 318.42B
Trailing P/E N/A
Forward P/E 131.22
PEG ratio (5-yr expected) 10.38
Price/sales (ttm)358.03
Price/book (mrq)N/A
Enterprise value/revenue 3376.99
Enterprise value/EBITDA 7-144.24

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3151.80
52-week low 336.15
50-day moving average 392.16
200-day moving average 383.95

Share statistics

Avg vol (3-month) 3857.82k
Avg vol (10-day) 3529.23k
Shares outstanding 5186.22M
Implied shares outstanding 6N/A
Float 79.72M
% held by insiders 155.92%
% held by institutions 121.79%
Shares short (14 Apr 2021) 41.66M
Short ratio (14 Apr 2021) 41.95
Short % of float (14 Apr 2021) 42.20%
Short % of shares outstanding (14 Apr 2021) 40.89%
Shares short (prior month 14 Mar 2021) 41.34M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Dec 2020

Profitability

Profit margin -264.21%
Operating margin (ttm)-273.27%

Management effectiveness

Return on assets (ttm)-10.17%
Return on equity (ttm)-38.63%

Income statement

Revenue (ttm)48.87M
Revenue per share (ttm)0.37
Quarterly revenue growth (yoy)-11.40%
Gross profit (ttm)34.75M
EBITDA -127.73M
Net income avi to common (ttm)-129.12M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.33B
Total cash per share (mrq)7.34
Total debt (mrq)55.28M
Total debt/equity (mrq)7.77
Current ratio (mrq)5.61
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)522.4M
Levered free cash flow (ttm)57.92M